Glucose Metabolism in Prostatic SCNC

In conclusion, this study suggests different pathways of glucose metabolism contribute to the disparate biologic behaviors of these two tumor types.
Implications: CD44 is an important regulator of glucose metabolism in small cell neuroendocrine carcinoma and may be an important therapeutic target. Mol Cancer Res; 14(4); 344–53. ©2016 AACR.

Source: Molecular Cancer Research - April 13, 2016 Category: Cancer & Oncology Authors: Li, W., Cohen, A., Sun, Y., Squires, J., Braas, D., Graeber, T. G., Du, L., Li, G., Li, Z., Xu, X., Chen, X., Huang, J. Tags: Cell Death and Survival Source Type: research